This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inoue, T. Articles by Morooka, S. Search for Related Content PubMed PubMed Citation Articles by Inoue, T. Articles by Morooka, S.

Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease

^a Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya, Saitama, Japan

View larger version (15K): [in a new window]   Figure 1 Comparison of the anti-Ox-LDL titer among the progression group, the no-change group and the regression group. The titer was higher in the progression group than in the regression group or the no-change group. There was no significant difference in the antibody titer between the regression group and the no-change group.

View larger version (14K): [in a new window]   Figure 2 Correlation between the Gensini score and the antibody against oxidized low density lipoprotein (anti-Ox-LDL) titer (left) and between the Progression-Regression score and the antibody titer (right). The anti-Ox-LDL titer did not correlate with the Gensini score, but correlated with the Progression-Regression score.